iOS 27: Your AirPods Can Now Replace Your Apple Watch
Oura is trying to go public before the leaves finish changing color. The smart ring maker is seeking to raise up to $3 billion in a U.S. IPO that could value the company above $16 billion — up from roughly $11 billion a year ago — with a listing that could land as early as this month, according to Bloomberg. If you’re one of the millions of people paying $5.99 a month to see your Readiness Score, this is the story that decides what your ring costs and who it answers to for the next several years.
We’ve been tracking Oura’s finances all year — the Ring 5 FCC leak in March put the company at an $11 billion valuation, and by the time a class-action lawsuit over its sleep-accuracy claims landed in late August, that number had already jumped to $16 billion. This is where the IPO story actually stands, what’s driving the number, and what it means for your subscription.
| What’s Known | |
|---|---|
| IPO target | Up to $3 billion raised, valuation above $16 billion |
| Prior valuation | ~$11 billion (Series E, September 2025, $875 million raised) |
| Confidential S-1 filed | May 21, 2026 |
| Possible listing date | As early as September 2026 |
| 2024 revenue | ~$500 million |
| 2025 revenue | ~$1 billion |
| 2026 projected revenue | Approaching $2 billion |
| Underwriters | Goldman Sachs, Morgan Stanley, JPMorgan, Allen & Co., Jefferies |
| Current subscription | $5.99/mo ($71.88/yr) after a 6-month free trial |
Best for: Anyone with an Oura subscription, or anyone deciding whether to buy a ring before pricing potentially shifts. Skip if: You want a final IPO date or price. Nothing’s official until Oura actually prices shares — this is still a reported target, not a done deal.
Strip away the headline number and here’s the sequence of events, sourced from Bloomberg’s reporting and corroborated by Investing.com and Yahoo Finance:
That’s a 45%-plus jump in valuation in roughly eleven months. For a company that sells a $349 ring and a $6-a-month app subscription, that’s an aggressive number, and it’s not happening in a vacuum.
The valuation jump tracks an actual, verifiable revenue curve, not just hype. Oura has disclosed that revenue went from roughly $500 million in 2024 to about $1 billion in 2025 — doubling in a single year — and the company is projecting close to $2 billion for 2026. That’s four times its 2024 revenue in two years, and it’s the kind of growth curve that makes bankers comfortable pricing a company at 8x forward revenue.
Some of that growth is straightforward: more rings sold, more people willing to pay for recovery data since WHOOP and Garmin normalized the idea. Some of it is subscription math compounding — every Ring 4 sold locks in a recurring $71.88/year, and Oura says it surpassed 5 million paid members in the second quarter of 2026. A ring is a one-time purchase. The membership fee is the part investors actually care about, because it’s predictable and it renews without Oura having to do anything.
Yes — Oura is actively preparing for a U.S. IPO, though nothing is final until shares actually price. Here’s what’s confirmed as of this writing:
We’ve written before about what happens to fitness app pricing after a company goes public, and the pattern isn’t subtle. Peloton raised its membership price within 18 months of its IPO. Fitbit moved core features behind a paywall after Google’s acquisition closed. Public companies answer to shareholders who want revenue growth every quarter, and the easiest lever any subscription business has is the subscription price.
Oura’s $5.99/month rate has held steady for a while now. That’s not a guarantee it survives an IPO. A newly public Oura with Wall Street analysts modeling ARPU growth has every incentive to introduce a higher tier, fold in currently-free features, or just raise the base price 20-30%. None of that requires new hardware. It just requires a shareholder letter that says “subscription revenue growth” and a product team told to find it.
If you’re on the current plan, there’s no action required today — nothing changes the morning after an S-1 goes public. But if you’re on a month-to-month plan, locking in an annual rate now protects you from whatever pricing decisions get made in the first year of being a public company. Same logic we gave WHOOP subscribers after its $575 million Series G pushed that company to a $10.1 billion valuation back in the spring.
It’s worth pausing on how differently Oura and WHOOP are approaching this moment, because six months ago the two were following similar playbooks and now they’ve split.
WHOOP raised $575 million in March at a $10.1 billion valuation — and stayed private. Abbott and Mayo Clinic came in as strategic investors, and the whole deal read as a company betting it can build toward FDA-cleared medical features before ever facing public-market scrutiny. Oura is doing the opposite: filing the paperwork, lining up five major banks, and reportedly aiming for a public listing within months at a valuation that’s now roughly 60% higher than WHOOP’s.
| Oura | WHOOP | |
|---|---|---|
| Path | Targeting public IPO, as early as Sept. 2026 | Stayed private, $575M Series G (March 2026) |
| Reported/actual valuation | Above $16B (target) | $10.1B (closed) |
| Revenue model | Hardware ($349 ring) + $5.99/mo subscription | Subscription-only ($199-360/yr, hardware bundled) |
| 2025 revenue | ~$1B | $1.1B bookings run rate |
Neither path is obviously right. Going public means quarterly earnings calls and analyst pressure starting almost immediately. Staying private with a nine-figure raise means WHOOP can keep operating out of public view, but its investors still eventually want a return — an IPO or acquisition down the line, just on a longer clock. Whichever way a wearable company scales, the subscriber ends up funding the growth either way.
One thing worth knowing if you’re weighing an Oura purchase or subscription renewal right now: a class-action lawsuit filed in August accuses Oura of overstating its “95% sleep staging accuracy” marketing claim, citing independent research that found accuracy closer to 53% in a clinical setting. That case doesn’t derail an IPO by itself — plenty of companies go public with pending litigation disclosed as a risk factor — but it does mean Oura’s forthcoming public S-1 will have to spell out the lawsuit for prospective investors in plain legal language. It’s one more variable for a company trying to convince Wall Street its core product claim holds up under scrutiny at the exact moment that claim is being tested in federal court.
If you’ve been sitting on the fence, the pre-IPO window is genuinely the moment to lock in current terms, not because Ring 5 is imminent (it’s probably a late 2026 to early 2027 device), but because $349 hardware and a $5.99/month subscription are numbers Oura has held stable for a while, and stability tends to end once a company starts answering to public shareholders.
That’s not a reason to panic-buy a ring you don’t need. It’s a reason to stop waiting if you were already planning to get one. Buying now locks in today’s pricing before a public listing gives Oura’s finance team a reason to revisit it.
If you’d rather sidestep the subscription question entirely, the no-subscription alternatives in this category — Garmin’s CIRQA, budget rings like Pebble — aren’t affected by any of this, because their business model was never built around a recurring fee that needs to grow every quarter.
An $11 billion company doesn’t usually add $5 billion in perceived value in eleven months without a real reason, and Oura’s revenue curve — $500 million to $1 billion to a projected $2 billion — is a real reason. This isn’t hype riding on a good press cycle. It’s a company that’s roughly quadrupled revenue in two years, and bankers are pricing the IPO accordingly.
But “the growth is real” and “nothing changes for subscribers” aren’t the same claim, and we’d be lying if we said the second one. Every company that’s made this exact jump — private wearable darling to public company with quarterly earnings — has used the transition to extract more revenue per user, not less. Oura’s $5.99/month has been a genuinely fair price relative to WHOOP’s $240+/year membership. There’s no reason to assume it stays that way once Oura has to explain subscriber growth to analysts every ninety days instead of to itself.
Oura is reportedly targeting a U.S. IPO as early as September 2026, seeking up to $3 billion at a valuation above $16 billion — a sharp jump from the $11 billion the company was worth less than a year ago, built on revenue that’s gone from $500 million to a projected $2 billion in two years. Nothing about your ring or your subscription changes today. But the historical pattern for fitness companies after they go public points in one direction on pricing, and it’s not down. If you’re already subscribed, lock in an annual rate while the current terms still hold. If you’re deciding whether to buy in, the pre-IPO window is the cheapest this product is likely to be for a while.
Details reflect Bloomberg’s reporting via TechCrunch, Investing.com, and Yahoo Finance on Oura’s IPO plans as of August 24-25, 2026, CNBC’s reporting on the May 21, 2026 confidential S-1 filing, and Oura’s disclosed revenue figures. This post will be updated if Oura’s IPO timeline, valuation, or pricing changes.